Atorvastatin 80mg Versus Atorvastatin 20mg in Perioperative Vascular Surgery to Evaluate Cardiovascular Outcomes.

Trial Profile

Atorvastatin 80mg Versus Atorvastatin 20mg in Perioperative Vascular Surgery to Evaluate Cardiovascular Outcomes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2010

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms APVS
  • Most Recent Events

    • 28 Aug 2010 Results presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 16 Jun 2010 Results were presented at the 17th World Congress of Cardiology.
    • 13 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top